Kharfan‐Dabaja, Mohamed A. ; Labopin, Myriam ; Brissot, Eolia ; Kroger, Nicolaus 
; Finke, Jürgen ; Ciceri, Fabio ; Deconinck, Eric ; Blaise, Didier ; Chevallier, Patrice ; Gramatzki, Martin ; Ganser, Arnold ; Stelljes, Matthias ; Edinger, Matthias ; Savani, Bipin ; Ruggeri, Annalisa ; Sanz, Jaime ; Nagler, Arnon ; Mohty, Mohamad
; Finke, Jürgen ; Ciceri, Fabio ; Deconinck, Eric ; Blaise, Didier ; Chevallier, Patrice ; Gramatzki, Martin ; Ganser, Arnold ; Stelljes, Matthias ; Edinger, Matthias ; Savani, Bipin ; Ruggeri, Annalisa ; Sanz, Jaime ; Nagler, Arnon ; Mohty, Mohamad 
Zusammenfassung
Optimal donor choice for a second allogeneic haematopoietic cell transplant (allo-HCT) in relapsed acute myeloid leukaemia (AML) remains unknown. We compared overall survival (OS) using registry data from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) involving 455 adults who received a second allo-HCT from a human leucocyte antigen ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Altmetric